background
nearli
children
infect
respiratori
syncyti
viru
rsv
within
first
year
life
minor
develop
sever
diseas
hospit
hypothes
assess
adapt
immun
system
use
tlymphocyt
transcriptom
would
identifi
gene
express
correl
diseas
sever
method
infant
infect
rsv
repres
extrem
clinic
sever
studi
mild
ill
n
defin
respiratori
rate
rr
room
air
oxygen
satur
sao
sever
ill
n
defin
rr
rna
fresh
sortpurifi
cell
assess
rna
sequenc
result
gestat
age
age
ill
onset
exposur
environment
tobacco
smoke
bacteri
colon
breastfeed
associ
adjust
p
diseas
sever
rna
sequenc
analysi
reliabl
measur
approxim
genom
sever
rsv
ill
greatest
effect
size
upon
tcell
gene
express
pathway
analysi
identifi
correl
sever
includ
jakstat
prolactin
interleukin
signal
also
identifi
gene
pathway
associ
time
symptom
rsv
group
ab
conclus
data
suggest
fundament
chang
adapt
immun
cell
phenotyp
may
associ
rsv
clinic
sever
respiratori
syncyti
viru
rsv
import
caus
respiratori
tract
ill
infant
young
children
infect
infant
first
year
life
although
infect
rel
mild
infect
infant
requir
hospit
account
admiss
infant
age
year
annual
unit
state
addit
rsvrelat
emerg
depart
visit
infant
age
year
age
rang
per
rsvrelat
offic
visit
time
mani
although
mani
risk
factor
sever
diseas
recogn
prematur
congenit
heart
diseas
pulmonari
diseas
neurolog
immunosuppress
condit
major
infant
brought
medic
attent
healthi
fullterm
infant
host
environment
factor
also
associ
sever
diseas
although
less
overt
male
sex
lack
breastfeed
tobacco
smoke
exposur
low
level
matern
deriv
protect
antibodi
host
immun
respons
also
thought
influenc
diseas
manifest
includ
sever
experiment
anim
model
rsv
infect
suggest
immunedomin
respons
well
diminish
impair
antiinflammatori
tregulatori
treg
cell
function
increas
respons
contribut
increas
lung
patholog
data
infant
studi
less
compel
support
other
refut
respons
respons
sever
diseas
recent
gene
express
analysi
whole
blood
collect
infect
use
assess
immun
respons
rsv
one
studi
note
increas
express
interferon
signal
neutrophil
gene
pathway
diminish
tand
bcell
gene
pathway
cell
critic
develop
adapt
immun
follow
infect
also
influenc
degre
inflamm
sought
investig
gene
express
pattern
use
highthroughput
rna
sequenc
rnaseq
isol
cell
healthi
fullterm
infant
age
month
time
primari
rsv
infect
compar
infant
mild
sever
clinic
diseas
identifi
uniqu
gene
express
pattern
implic
biolog
pathway
associ
diseas
sever
provid
novel
insight
pathogenesi
rsv
infect
popul
research
subject
review
board
univers
rochest
medic
center
urmc
rochest
gener
hospit
approv
studi
parent
provid
written
inform
consent
respiratori
syncyti
virusinfect
infant
select
analysi
cohort
part
aspir
studi
rsv
pathogenesi
birth
cohort
enrol
august
decemb
follow
combin
passiv
activ
surveil
develop
rsv
infect
subsequ
winter
infant
respiratori
symptom
evalu
home
rsv
infect
use
rsv
groupspecif
revers
transcriptasepolymeras
chain
reaction
rtpcr
assay
second
cohort
enrol
seen
acut
respiratori
symptom
pediatr
offic
emerg
room
test
rsv
antigen
detect
quidel
san
diego
ca
rtpcr
third
cohort
consist
infant
hospit
rsv
urmc
golisano
children
hospit
elig
subject
fullterm
wk
gestat
healthi
infant
born
previou
may
age
month
rsv
infect
ensur
primari
infect
hospit
infant
seen
daili
discharg
chart
review
sign
respiratori
ill
lowest
room
air
oxygen
satur
sao
infant
evalu
member
studi
team
physician
project
nurs
demograph
data
ill
symptom
find
physic
examin
result
standard
laboratori
chest
radiograph
result
avail
record
defin
visit
acut
ill
onset
determin
physician
interview
parent
evalu
follow
evalu
nasal
swab
use
infants
flock
swab
floqswab
catalog
copan
murrieta
ca
place
ml
steril
ultravioletinactiv
water
ml
heparin
blood
collect
second
blood
sampl
collect
second
visit
convalesc
day
ill
onset
nasal
swab
use
detect
respiratori
viru
coinfect
streptococcu
pneumonia
haemophilu
influenza
use
taqman
multiplex
assay
separ
moraxella
catarrhali
accord
publish
method
heparin
blood
maintain
room
temperatur
hour
peripher
blood
mononuclear
cell
isol
ficollhypaqu
gradient
flowsort
subset
includ
lymphocyt
store
rna
lysi
buffer
rna
sequenc
perform
previous
describ
start
ng
rna
use
smarter
ultra
low
amplif
kit
clontech
mountain
view
ca
librari
construct
use
nexteraxt
librari
kit
illumina
san
diego
ca
sequenc
illumina
gener
approxim
million
singl
endread
per
sampl
preanalysi
data
process
previous
describ
categor
variabl
use
samseq
identifi
gene
signific
differ
mean
express
q
pearson
spearman
correl
test
benjaminihochberg
correct
control
fals
discoveri
rate
level
use
select
gene
signific
correl
continu
variabl
also
conduct
multivari
linear
mixedeffect
regress
analysi
studi
linear
associ
express
individu
gene
respons
variabl
variou
import
demograph
clinic
environ
variabl
see
supplementari
method
differenti
express
gene
use
canon
pathway
identif
upstream
regul
analysi
use
ingenu
pathway
analysi
qiagen
redwood
citi
ca
assess
tcell
transcript
factor
activ
interpret
gene
express
pattern
associ
sever
use
bayesian
estim
transcript
factor
activ
quantit
polymeras
chain
reaction
perform
select
gene
confirm
gene
express
describ
p
valu
consid
statist
signific
continu
clinic
variabl
perform
welch
test
check
equal
mean
valu
patient
group
defin
diseas
sever
binari
variabl
fisher
exact
test
use
breastfeed
model
categor
variabl
none
exclus
test
use
spearman
rank
correl
rsvinfect
infant
enrol
studi
select
repres
extrem
end
sever
spectrum
mild
diseas
n
birth
cohort
n
second
cohort
defin
maximum
respiratori
rate
rrmax
per
minut
sao
sever
diseas
hospit
cohort
defin
rrmax
subject
sever
ill
significantli
younger
vs
month
p
like
expos
environment
tobacco
smoke
vs
p
less
like
breastf
vs
p
tabl
viral
coinfect
similar
group
group
equal
colon
moraxella
catarrhali
sever
ill
group
significantli
like
colon
pneumonia
andor
h
influenza
vs
p
although
infant
consid
full
term
sever
clinic
symptom
born
slightli
lower
gestat
age
cell
group
infant
sort
subject
rnaseq
analysi
total
sampl
subject
n
group
pass
qualiti
control
qc
remain
sampl
remov
analysi
raw
read
map
rate
gene
detect
rate
shown
figur
sampl
averag
approxim
read
map
rate
filter
analyt
data
set
includ
express
valu
gene
interestingli
cell
appear
express
approxim
genom
consist
prior
data
sort
lymphocyt
assess
cell
marker
eg
mpo
confirm
puriti
sort
cell
supplementari
figur
univari
analysi
use
identifi
gene
express
pattern
associ
clinic
demograph
variabl
tabl
analysi
demonstr
clinic
sever
associ
greatest
effect
size
upon
gene
express
n
gene
effect
size
clinic
sever
much
greater
sex
n
gene
rsv
group
ab
n
gene
day
sinc
onset
clinic
symptom
n
gene
interestingli
found
bacteri
cocolon
seem
greater
effect
n
gene
viral
coinfect
n
gene
appreci
potenti
confound
variabl
influenc
identif
signific
gene
express
pattern
construct
multivari
linear
mixedeffect
regress
model
includ
variabl
greatest
margin
effect
number
signific
gene
identifi
conserv
analysi
summar
tabl
detail
gene
identifi
includ
relationship
individu
variabl
provid
supplementari
tabl
multivari
model
sever
ill
continu
strongest
associ
gene
express
n
gene
albeit
slightli
greater
sex
n
gene
multivari
model
show
signific
gene
express
associ
day
sinc
onset
clinic
symptom
n
gene
rsv
group
n
gene
gestationl
age
n
gene
addit
multivari
model
also
identifi
substanti
number
gene
significantli
associ
viral
coinfectionbacteri
colon
statu
n
gene
found
pathogen
bacteria
colon
alon
significantli
associ
gene
express
n
gene
heat
map
gene
associ
diseas
sever
identifi
multivari
analysi
stratifi
time
sinc
onset
clinic
symptom
shown
figur
data
demonstr
populationlevel
heterogen
particularli
sever
affect
subject
suggest
greater
differ
gene
express
acut
phase
convalesc
phase
geneset
analysi
use
interpret
express
pattern
gene
associ
sever
liber
univari
analysi
n
gene
conserv
multivari
analysi
n
gene
identifi
number
signal
pathway
intercellular
signal
molecul
may
associ
clinic
respons
rsvinfect
infant
figur
supplementari
figur
although
limit
confirm
signific
individu
gene
level
multivari
gene
also
identifi
univari
analysi
high
degre
confirm
canon
pathway
discoveri
figur
observ
consist
robust
pathwaybas
approach
analysi
transcriptom
data
gene
associ
sever
predict
activ
jak
stat
prolactin
interleukin
ino
phosphatidylinositol
akt
signal
pathway
note
sever
affect
subject
interleukin
pathway
signal
also
predict
alter
unclear
whether
pathway
activ
inhibit
identif
pathway
predominantli
driven
gene
demonstr
b
pathway
associ
sever
phenotyp
ingenu
pathway
analysi
ipa
use
identifi
canon
pathway
repres
gene
associ
sever
lymphocyt
respiratori
syncyti
virusinfect
subject
variabl
use
gener
gene
set
ipa
multivari
sever
phenotyp
n
univari
sever
phenotyp
b
n
thirteen
pathway
shown
fisher
exact
test
p
valu
least
variabl
orang
blue
circl
indic
predict
increas
decreas
pathway
activ
activ
z
score
respect
gene
includ
pathway
list
color
red
increas
sever
subject
green
decreas
sever
subject
gene
increas
bold
regul
associ
tcell
gene
express
sever
ill
infant
implic
shift
arachidon
metabol
activ
major
antioxid
pathway
also
associ
tcell
gene
express
sever
ill
infant
analysi
also
suggest
activ
number
regul
mitogenesi
includ
myc
kra
togeth
data
support
conclus
broad
chang
tcell
activ
surviv
associ
clinic
sever
rsvinfect
infant
fact
observ
gene
express
chang
specif
implic
respons
associ
tcell
subtyp
regul
signal
figur
also
note
increas
activ
increas
express
suppressor
cytokin
signal
soc
gene
cell
sever
subject
particularli
antagon
soc
protein
togeth
regul
earli
differenti
effort
directli
test
whether
severityassoci
chang
gene
express
consist
alter
tcell
subtyp
implement
bayesian
estim
transcript
factor
activ
predict
transcript
factor
activ
base
upon
gene
express
pattern
associ
sever
found
chang
activ
predict
significantli
associ
sever
defin
univari
model
p
wherea
rora
margin
signific
p
smad
signific
p
transcript
activ
requir
thelper
differenti
also
play
role
differenti
cell
data
support
interpret
chang
tcell
subtyp
differenti
associ
sever
rsv
infect
explor
biolog
interpret
gene
associ
time
sinc
onset
clinic
symptom
figur
analysi
focus
set
gene
significantli
associ
stage
visitacut
versu
convalesc
anticip
activ
interferon
signal
note
earli
clinic
cours
base
assess
canon
pathway
gene
express
figur
upstream
regul
predict
figur
interestingli
type
ifnab
type
ii
ifng
type
iii
ifnl
interferon
respons
implic
confirm
signific
enrich
target
gene
p
respect
associ
downstream
chang
inflammasom
activ
implic
predict
mav
upstream
regul
figur
chang
viral
pattern
recognit
signal
potenti
driven
predominantli
increas
gene
also
identifi
interestingli
decreas
prolif
activ
cell
indic
reduct
also
observ
rsv
group
ab
associ
clinic
diseas
sever
independ
associ
signific
differ
tcell
transcriptom
statu
tabl
pathwaybas
interpret
gene
express
respons
identifi
signal
pathway
may
differenti
affect
infect
rsv
group
figur
base
upon
canon
pathway
analysi
adenineadenosin
salvag
ppar
sapkjnk
signal
predict
differenti
regul
rsv
subgroup
infect
interestingli
upstream
regul
analysi
figur
suggest
rictor
relat
clock
may
play
signific
role
respons
attempt
valid
express
estim
gene
select
base
upon
rnaseq
detect
level
biolog
interest
figur
supplementari
tabl
express
gene
demonstr
signific
concord
rnaseq
data
p
express
level
low
like
sourc
failur
valid
express
estim
among
gene
quantit
polymeras
chain
reaction
express
estim
confirm
express
significantli
associ
sever
figur
supplementari
tabl
wherea
significantli
associ
time
sinc
onset
clinic
symptom
figur
supplementari
tabl
full
understand
cellular
immun
mechan
underli
diseas
sever
rsv
infect
infant
elus
especi
normal
fullterm
healthi
infant
popul
compris
major
infant
brought
medic
attent
studi
investig
rsv
diseas
pathogenesi
measur
presenc
level
variou
inflammatori
protein
cytokin
chemokin
blood
respiratori
secret
vitro
product
peripher
blood
mononuclear
cell
often
dispar
result
recent
analysi
gene
express
wholeblood
sampl
use
microarray
rsvinfect
infant
report
center
studi
rsvinfect
infant
show
extens
activ
innat
immun
respons
specif
interferon
signal
network
could
identifi
differ
accord
diseas
sever
much
larger
studi
involv
rsvinfect
infant
mild
sever
rsv
diseas
mejia
colleagu
report
overexpress
neutrophil
inflamm
interferon
gene
suppress
tand
bcell
gene
studi
sever
ill
associ
greater
express
neutrophil
inflamm
gene
mildli
ill
subject
wherea
mildli
ill
subject
show
overexpress
innat
immun
gene
cell
import
earli
adapt
immun
respons
rsv
associ
degre
inflamm
infect
chose
investig
gene
express
pattern
isol
cell
infant
primari
rsv
infect
differ
sever
first
year
life
optim
identif
differenti
express
gene
select
infant
extrem
diseas
sever
interrog
tcell
gene
express
subject
identifi
number
pathway
interest
includ
prolactin
signal
jakstat
signal
signal
signal
data
indic
sever
ill
rsvinfect
infant
display
greater
activ
prolactin
signal
cell
prolactin
polypeptid
hormon
origin
pituitari
gland
shown
bind
prolactin
receptor
express
cell
varieti
effect
cell
prolactin
induct
tbet
transcript
phosphoryl
invers
dose
depend
suggest
exposur
cell
high
level
prolactin
might
reduc
function
anoth
studi
found
treg
cell
express
prolactin
receptor
exposur
prolactin
inhibit
suppress
effect
cell
vitro
interestingli
report
infant
sever
rsv
diseas
admit
intens
care
unit
significantli
higher
serum
prolactin
level
moder
ill
infant
cytokin
jakstat
signal
pathway
integr
product
innat
type
interferon
thu
surpris
pathway
differenti
express
accord
diseas
sever
confirm
effect
detect
circul
purifi
cell
novel
known
rsv
protein
block
type
effect
via
degrad
transcript
activ
soc
gene
includ
jakstat
pathway
gene
overexpress
sever
ill
subject
report
express
immun
respons
vitro
experi
exposur
murin
respiratori
epitheli
cell
rsv
stat
soc
key
regul
tcell
differenti
matur
function
similar
stat
soc
may
crossregul
one
anoth
protein
differenti
express
th
cell
lineag
favor
differenti
favor
differenti
compens
differenti
also
surpris
find
pathway
activ
increas
sever
rsv
diseas
signal
thought
import
role
tcell
differenti
function
includ
treg
respiratori
syncyti
viru
shown
rapidli
activ
pathway
associ
inhibit
cellular
apoptosi
well
increas
inflammatori
cytokin
product
interleukin
cytokin
produc
cell
eosinophil
neutrophil
found
upper
lower
airway
secret
infant
rsv
bronchiol
rel
high
level
previous
correl
diseas
sever
murin
model
rsv
infect
deplet
enhanc
clearanc
viru
lung
author
conclud
promot
inflammatori
respons
togeth
data
support
model
shift
tcell
subtyp
toward
phenotyp
associ
sever
ill
rsvinfect
infant
studi
particularli
larger
heterogen
popul
requir
confirm
observ
determin
whether
chang
mechanist
pure
result
ill
exclus
infant
wellknown
risk
factor
sever
diseas
allow
us
remov
influenc
analysi
although
use
formal
sever
score
system
defin
diseas
sever
popul
believ
clinic
criteria
select
provid
valid
separ
mild
sever
diseas
use
sort
cell
rather
whole
blood
rnaseq
uniqu
aspect
studi
add
exist
gene
express
literatur
potenti
limit
method
find
might
affect
manipul
cell
purif
sort
howev
critic
ident
procedur
use
process
sampl
subject
regardless
diseas
sever
blood
sampl
collect
kept
room
temperatur
process
immedi
therefor
impact
sampl
process
applic
subject
result
mostli
limit
sensit
summari
abl
identifi
number
differenti
express
gene
gene
pathway
involv
primari
rsv
infect
fullterm
healthi
infant
associ
increas
diseas
sever
result
may
help
ultim
identifi
potenti
biomark
sever
diseas
provid
put
intermedi
molecular
phenotyp
diseas
assay
use
experiment
vitro
vivo
infect
model
rsv
supplementari
materi
avail
journal
infecti
diseas
onlin
consist
data
provid
author
benefit
reader
post
materi
copyedit
sole
respons
author
question
comment
address
correspond
author
